NCT05008757

Brief Summary

Comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 17, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

August 31, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

8 months

First QC Date

July 9, 2021

Last Update Submit

June 25, 2023

Conditions

Indirect Calorimetry

Keywords

indirect calorimetry

Outcome Measures

Primary Outcomes (1)

  • resting energy expenditure

    comparison of resting energy expenditure measured using Q-NRG calorimeter with resting energy expenditure measured using Deltatrac II

    during the calorimetry

Interventions

no drugOTHER

no intervention

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers who practice more than 1 hour per day at moderate intensity

You may qualify if:

  • healthy adult
  • sport practice \> 1h per day at moderate intensity

You may not qualify if:

  • refusal to participate
  • unable to give a consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marjorie Fadeur

Liège, 4000, Belgium

RECRUITING

Study Officials

  • Anne-Françoise Rousseau, MD, PhD

    University Hospital of Liège, Belgium

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marjorie Fadeur, RD

CONTACT

+33042843413marjorie.fadeur@chuliege.be

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Clinic

Study Record Dates

First Submitted

July 9, 2021

First Posted

August 17, 2021

Study Start

August 31, 2021

Primary Completion

April 30, 2022

Study Completion

July 1, 2023

Last Updated

June 27, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations

BE(1)